Literature DB >> 31593797

Thresholds for clinical importance were defined for the European Organisation for Research and Treatment of Cancer Computer Adaptive Testing Core-an adaptive measure of core quality of life domains in oncology clinical practice and research.

Johannes M Giesinger1, Fanny L C Loth2, Neil K Aaronson3, Juan I Arraras4, Giovanni Caocci5, Fabio Efficace6, Mogens Groenvold7, Marieke van Leeuwen3, Morten Aa Petersen7, John Ramage8, Krzysztof A Tomaszewski9, Teresa Young10, Bernhard Holzner2.   

Abstract

OBJECTIVES: The aim of this article was to establish thresholds for clinical importance (TCIs) for the European Organisation for Research and Treatment of Cancer (EORTC) Computer Adaptive Testing (CAT) Core measure, the new adaptive version of the EORTC QLQ-C30. STUDY DESIGN AND
SETTING: For our diagnostic study, we recruited cancer patients with mixed diagnoses and treatments from six European countries. Patients completed the EORTC CAT Core and a questionnaire with anchor items assessing criteria for clinical importance (limitations in everyday life, need for help/care, and worries by the patient/family/partner) for each EORTC CAT Core domain. We used a binary variable summarizing the anchor items for determining TCIs and for calculating the area under the curve (AUC) in receiving operator characteristic analysis as a measure of diagnostic accuracy.
RESULTS: Using data from 498 cancer patients (mean age 60.4 years, 55.2% women), we established TCIs for the 14 domains of the EORTC CAT Core. Median AUC across domains was 0.93 (range 0.84-0.94). Median sensitivity and specificity of the TCIs were 0.91 (range 0.80-0.96) and 0.77 (range 0.66-0.84), respectively. TCIs and AUCs were largely consistent across patient groups.
CONCLUSION: We have generated TCIs for the 14 functional health and symptom domains of the EORTC CAT Core. The EORTC CAT Core showed high diagnostic accuracy in identifying clinically important symptoms and functional impairments.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical oncology; Clinical significance; Cut-offs; EORTC CAT core; Patient-reported outcome measures; Quality of life; Thresholds

Year:  2019        PMID: 31593797     DOI: 10.1016/j.jclinepi.2019.09.028

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

1.  Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.

Authors:  Silke Tribius; Sven Haladyn; Henning Hanken; Chia-Jung Busch; Andreas Krüll; Cordula Petersen; Corinna Bergelt
Journal:  Strahlenther Onkol       Date:  2020-12-30       Impact factor: 3.621

2.  Fatigue in breast cancer patients on chemotherapy: a cross-sectional study exploring clinical, biological, and genetic factors.

Authors:  Aline Hajj; Rami Chamoun; Pascale Salameh; Rita Khoury; Roula Hachem; Hala Sacre; Georges Chahine; Joseph Kattan; Lydia Rabbaa Khabbaz
Journal:  BMC Cancer       Date:  2022-01-03       Impact factor: 4.430

3.  Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancer.

Authors:  Emma Lidington; Johannes M Giesinger; Silvie H M Janssen; Suzanne Tang; Sam Beardsworth; Anne-Sophie Darlington; Naureen Starling; Zoltan Szucs; Michael Gonzalez; Anand Sharma; Bhawna Sirohi; Winette T A van der Graaf; Olga Husson
Journal:  Qual Life Res       Date:  2022-04-27       Impact factor: 3.440

4.  Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.

Authors:  Stephen Clarke; Belinda E Butcher; Andrew J McLachlan; Jeremy D Henson; David Rutolo; Sean Hall; Luis Vitetta
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.